TimeX Capital Strengthens Healthcare Expertise with Appointment of Kimberly Negrin, Ph.D.

WASHINGTON, DC – September 23, 2025 – TimeX Capital, a Next-Generation investment bank specializing in high-growth and innovation-driven industries, is proud to announce its continued expansion into the BioTech and MedTech sectors. As part of this strategic initiative, Kimberly Negrin, Ph.D., has been appointed as an Executive Director in Healthcare.

Kimberly brings over a decade of leadership at the intersection of science, strategy, and commercialization. She has built a career guiding life sciences and biotech companies through market entry, strategic growth, and brand positioning—helping translate bold scientific ideas into impactful commercial ventures.

Kimberly also serves as the Founder of Bloom Bio, a boutique consultancy specializing in technology advisory, commercialization strategy, fractional leadership, and executive coaching for life science companies. Her approach uniquely blends deep scientific expertise with practical business acumen, enabling early-stage and growth-stage innovators to accelerate their impact.

A passionate advocate for leadership development, Kimberly is dedicated to coaching technical founders and underserved entrepreneurs, particularly women in biotech. She also serves as a judge, mentor, and faculty member for the Biotools Innovator Accelerator, the world’s largest accelerator focused exclusively on BioTools, and has held advisory roles across cell therapy, regenerative medicine, and industry associations such as the Association for Women in Science (AWIS).

Kimberly Negrin, Ph.D.,

Kimberly earned her Ph.D. in Biomedical Science from the University of Massachusetts Medical School, where her research focused on immunometabolism and lipid-based delivery systems, including liposome protocols foundational to today’s lipid nanoparticle technologies.

"My decision to partner with TimeX was driven by our shared vision that true healthcare innovation requires more than capital—it requires strategic commercialization expertise and a commitment to empowering founders. With TimeX, I can pair my experience working alongside entrepreneurs with the financial tools and partnerships needed to accelerate growth. Together, we will unlock the full potential of the next generation of biotech and healthcare innovators."

-Kimberly Negrin Ph.D.

"We are thrilled to welcome Kimberly Negrin to TimeX Capital’s Healthcare team. Her exceptional blend of scientific rigor, strategic foresight, and dedication to empowering founders aligns seamlessly with our mission to redefine investment banking by prioritizing innovation and impact. She's proven her expertise over the years, guiding life science companies through complex commercialization journeys. This wisdom will be invaluable to our clients, particularly those in BioTech and MedTech. Her passion for mentoring technical and underserved entrepreneurs further strengthens our commitment to fostering equitable innovation. With Kimberly’s addition to our Healthcare team, we are poised to deliver unparalleled value to our clients, helping them transform bold ideas into transformative healthcare solutions."

-Arun Subramony, TimeX Chairman & CEO

About TimeX Capital LLC

TimeX Capital LLC is a pioneering investment banking firm that redefines and disrupts the traditional investment banking model by prioritizing Time as the most critical stakeholder. TimeX dedicates itself to serving Founders and Entrepreneurs in Healthcare, Sustainable Infrastructure, and Digital Intelligence. TimeX focuses on long-term value creation with a skin-in-the-game approach, leveraging its ability to aggregate, value, and monetize IP assets of its client's businesses. These traits make TimeX a refreshing and differentiated player in its ability to transform companies globally.